V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 320003099 | 320001854 | 1.5 | 55.8 | Palliative (P) | 2018-10-23 | 2018-10-30 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 320018267 | CARBOPLATIN + RT |
| 320003100 | 320001855 | 1.67 | 76 | Not known (9) | 2016-03-16 | 2016-03-16 | Cisplatin + Docetaxel +Fluorouracil | N | null | 320018272 | DOCETAXEL |
| 320003101 | 320004945 | 1.84 | 71 | Palliative (P) | 2014-07-05 | 2014-07-09 | Capecitabine (21days) + Carboplatin | N | N | 320018277 | CARBO + FLUOROURACIL |
| 320003102 | 320001856 | 1.7 | 135 | Palliative (P) | 2016-09-20 | 2016-10-20 | CARBOPLATIN + Cetuximab + FLUOROURACIL | null | N | 320018285 | CISPLATIN + GEMCITABINE |
| 320003103 | 320001856 | 1.84 | 69 | Palliative (P) | 2017-12-28 | 2017-12-29 | CAPECITABINE + CETUXIMAB | N | N | 320018285 | CARBOPLATIN + LIPOSOMAL DOX |
| 320003104 | 320001857 | null | 68.8 | Palliative (P) | 2014-08-29 | 2014-09-10 | Carbo F | N | N | 320018290 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 320003105 | 320001857 | 1.74 | 90 | Palliative (P) | 2016-03-28 | 2016-03-29 | IPILIMUMAB + NIVOLUMAB | N | N | 320018290 | CETUXIMAB |
| 320003106 | 320001858 | 1.68 | 109.6 | Curative (C) | 2014-12-23 | 2014-12-28 | Trial Unspecified | 2 | N | 320018305 | CARBO + FLUOROURACIL |
| 320003107 | 320001859 | 1.73 | 130.8 | 1 | 2016-04-20 | 2016-04-24 | Cisplatin + Docetaxel +Fluorouracil | 02 | null | 320018329 | VINFLUNINE |
| 320003108 | 320004948 | 1.67 | 56.4 | Neo-adjuvant (N) | 2013-04-01 | 2013-04-02 | Cisplatin + Fluorouracil + RT 5day | 02 | N | 320018330 | POUT TRIAL |
| 320003109 | 320001860 | 1.82 | 55 | Curative (C) | 2016-05-08 | 2016-06-03 | EC | 02 | Y | 320018333 | CAPECITABINE + GEMCITABINE |
| 320003110 | 320001861 | 1.9 | 73.7 | Neo-adjuvant (N) | 2017-04-22 | 2017-04-27 | Capecitabine | 2 | N | 320018354 | CARBOPLATIN + RT |
| 320003111 | 320001862 | null | 109 | Neo-adjuvant (N) | 2016-12-28 | 2017-01-12 | Cetuximab + Radiotherapy Load | Y | null | 320018363 | MITOMYCIN INTRAVESICULAR |
| 320003112 | 320001863 | 1.66 | 82.8 | Neo-adjuvant (N) | 2013-11-11 | 2013-11-11 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 320018370 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 320003113 | 320001863 | 1.71 | 62.3 | Neo-adjuvant (N) | null | 2014-02-20 | Oxaliplatin + Modified de Gramont | N | N | 320018370 | TIP |
| 320003114 | 320001864 | 1.64 | null | Palliative (P) | 2014-11-05 | 2014-11-20 | TIP | 2 | Y | 320018378 | CETUXIMAB + CISPLATIN + FU |
| 320003115 | 320001864 | 1.67 | 93 | Palliative (P) | 2017-07-20 | 2017-07-20 | CAPECITABINE + OXALIPLATIN | N | N | 320018378 | TEMOZOLOMIDE + RT |
| 320003116 | 320001864 | 1.58 | 71.45 | Palliative (P) | 2013-11-19 | 2014-02-15 | PEMBROLIZUMAB | 02 | N | 320018378 | CAPECITABINE + OXALIPLATIN |
| 320003117 | 320001864 | 1.6 | 75.8 | Neo-adjuvant (N) | 2016-06-26 | 2016-07-13 | Cisplatin + Docetaxel | N | N | 320018378 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 320003119 | 320001866 | 1.52 | 85.3 | Neo-adjuvant (N) | 2014-09-21 | 2014-10-16 | PEMBROLIZUMAB | null | N | 320018405 | CETUXIMAB + CISPLATIN + FU |
| 320003120 | 320004951 | 1.61 | 55.2 | Neo-adjuvant (N) | null | 2013-10-01 | Carboplatin + Liposomal Doxorubicin | N | null | 320018416 | CARBO + LIPOSOMAL DOX + PACLITAXEL |
| 320003121 | 320004951 | 0 | 60.3 | Curative (C) | 2014-08-07 | 2014-08-20 | Liposomal Doxorubicin (Caelyx) | Y | N | 320018416 | THALIDOMIDE |
| 320003122 | 320001867 | 1.81 | 92.5 | Neo-adjuvant (N) | 2015-06-05 | 2015-06-09 | PEMBROLIZUMAB | 02 | N | 320018422 | CISPLATIN + GEMCITABINE |
| 320003123 | 320001868 | 1.73 | 58.4 | Not known (9) | 2013-12-11 | 2013-12-11 | Carboplatin + Etoposide iv&po | 02 | N | 320018449 | ECX |
| 320003124 | 320001869 | 1.8 | null | Palliative (P) | 2015-09-09 | 2015-09-29 | Imatinib 400mg | N | N | 320018464 | CETUXIMAB + CISPLATIN + FU |
| 320003125 | 320001869 | 1.78 | 107.7 | Curative (C) | 2016-04-16 | 2016-04-30 | CARBOPLATIN + RT | N | Y | 320018464 | CAPECITABINE + CISPLATIN |
| 320003126 | 320001869 | 1.55 | 75.8 | Not known (9) | 2014-04-11 | 2014-04-11 | Carboplatin + Etoposide iv&po | 1 | N | 320018464 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 320003127 | 320001870 | 1.7 | 50.1 | Neo-adjuvant (N) | 2015-07-02 | 2015-07-11 | FLUOROURACIL + OXALIPLATIN | N | N | 320018486 | ICON TRIAL |
| 320003128 | 320001870 | 1.63 | 33.2 | Palliative (P) | 2016-02-20 | 2016-03-08 | CETUXIMAB + RT | N | N | 320018486 | TEMOZOLOMIDE + RT |
| 320003129 | 320001871 | 1.7 | 104.4 | Curative (C) | 2017-04-27 | 2017-05-03 | TIP | 02 | N | 320018500 | CISPLATIN + GEMCITABINE |
| 320003130 | 320001872 | 1.64 | 96.2 | Not known (9) | 2014-08-19 | 2014-08-19 | CISPLATIN + GEMCITABINE | 01 | null | 320018515 | CISPLATIN + ETOPOSIDE |
| 320003131 | 320001873 | 1.75 | 56 | Palliative (P) | 2014-05-26 | 2014-05-30 | Dacarbazine | 02 | N | 320018528 | LANREOTIDE |
| 320003132 | 320001874 | 1.61 | 63.3 | Neo-adjuvant (N) | 2015-08-21 | 2015-08-21 | Carboplatin + Etoposide IV 3 day | N | N | 320018544 | CISPLATIN + GEMCITABINE |
| 320003133 | 320001875 | 1.63 | 66.6 | Curative (C) | 2014-09-11 | 2014-09-18 | PEMBROLIZUMAB | N | Y | 320018548 | BCG |
| 320003134 | 320001876 | 1.09 | 66.9 | Palliative (P) | 2015-06-18 | 2015-07-10 | GEMCITABINE | N | N | 320018553 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 320003135 | 320001876 | 1.71 | 73.6 | Curative (C) | 2013-04-02 | 2013-04-12 | Gemcitabine weekly | 02 | Y | 320018553 | ECF |
| 320003136 | 320001877 | null | 105 | Adjuvant (A) | 2015-01-30 | 2015-02-07 | IBRUTINIB | N | N | 320018583 | ATEZOLIZUMAB |
| 320003138 | 320004955 | null | 54.2 | Palliative (P) | 2014-10-20 | 2014-10-27 | ICON8 TRIAL | 02 | N | 320018590 | ICON TRIAL |
| 320003139 | 320006319 | 1.64 | 65 | null | 2018-04-22 | 2018-04-25 | Oxaliplatin + Modified de Gramont | N | N | 320018601 | DACARBAZINE |
| 320003140 | 320006319 | 1.61 | 68 | Curative (C) | 2017-04-02 | 2017-04-16 | CISPLATIN + GEMCITABINE | 02 | Y | 320018601 | CAPECITABINE |
| 320003141 | 320007219 | 1.94 | 104.7 | Adjuvant (A) | null | 2014-08-25 | CHOP R - 21 days | N | N | 320018612 | CARBO + FLUOROURACIL |
| 320003142 | 320001879 | 1.54 | 86.4 | Palliative (P) | 2016-04-24 | 2016-05-08 | Oxaliplatin + Modified de Gramont | Y | N | 320018617 | DOXORUBICIN |
| 320003143 | 320001880 | 1.09 | null | Palliative (P) | 2016-02-09 | 2016-02-16 | HCX (Cape + Cisp + Tras) - Load | N | N | 320018619 | ICON TRIAL |
| 320003144 | 320001881 | 1.5 | 48 | Palliative (P) | 2014-04-11 | 2014-04-16 | Carboplatin + Etoposide iv&po | 02 | N | 320018628 | LANREOTIDE |
| 320003145 | 320001882 | 1.76 | 109.6 | Curative (C) | 2015-02-10 | 2015-03-08 | FLUOROURACIL + MITOMYCIN + RT | null | Y | 320018642 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 320003146 | 320001883 | null | 54 | Palliative (P) | null | 2016-07-14 | Mitomycin Intravesical | null | null | 320018650 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 320003147 | 320001884 | null | 52.2 | Adjuvant (A) | 2015-01-30 | 2015-02-03 | Trial Unspecified | 02 | N | 320018651 | CYCLOPHOSPHAMIDE + DACTINOMYCIN + VINCRISTINE |
| 320003148 | 320001885 | 1.71 | 85.1 | Palliative (P) | null | 2016-11-11 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 320018655 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 320003149 | 320001885 | null | null | Adjuvant (A) | 2014-05-02 | 2014-05-21 | null | N | N | 320018655 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 320003150 | 320001886 | 1.78 | 89 | Curative (C) | 2016-09-26 | 2016-09-28 | Folfirinox | 02 | N | 320018658 | ECX |